DK1622926T3 - Hidtil ukendt fremgangsmåde og mellemprodukter til fremstilling af 19-nor-steroid-17-halogensammensætninger - Google Patents

Hidtil ukendt fremgangsmåde og mellemprodukter til fremstilling af 19-nor-steroid-17-halogensammensætninger

Info

Publication number
DK1622926T3
DK1622926T3 DK04742578T DK04742578T DK1622926T3 DK 1622926 T3 DK1622926 T3 DK 1622926T3 DK 04742578 T DK04742578 T DK 04742578T DK 04742578 T DK04742578 T DK 04742578T DK 1622926 T3 DK1622926 T3 DK 1622926T3
Authority
DK
Denmark
Prior art keywords
steroid
intermediates
preparation
new process
halogen compositions
Prior art date
Application number
DK04742578T
Other languages
Danish (da)
English (en)
Inventor
Francois Nique
Christian Moratille
Patrick Roussel
Joelle Bousquet
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1622926T3 publication Critical patent/DK1622926T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
DK04742578T 2003-04-29 2004-04-27 Hidtil ukendt fremgangsmåde og mellemprodukter til fremstilling af 19-nor-steroid-17-halogensammensætninger DK1622926T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0305222A FR2854403B1 (fr) 2003-04-29 2003-04-29 Nouveau procede et intermediaires de preparation de composes 19-nor-steroides 17-halogenes
PCT/FR2004/001011 WO2004096829A2 (fr) 2003-04-29 2004-04-27 Nouveau procede et intermediaires de preparation de composes 19-nor-steroïdes-17-halogenes

Publications (1)

Publication Number Publication Date
DK1622926T3 true DK1622926T3 (da) 2009-11-16

Family

ID=33155513

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04742578T DK1622926T3 (da) 2003-04-29 2004-04-27 Hidtil ukendt fremgangsmåde og mellemprodukter til fremstilling af 19-nor-steroid-17-halogensammensætninger

Country Status (15)

Country Link
US (1) US7449572B2 (es)
EP (1) EP1622926B1 (es)
JP (1) JP4629030B2 (es)
AR (1) AR044103A1 (es)
AT (1) ATE435869T1 (es)
CY (1) CY1109434T1 (es)
DE (1) DE602004021918D1 (es)
DK (1) DK1622926T3 (es)
ES (1) ES2328927T3 (es)
FR (1) FR2854403B1 (es)
PL (1) PL1622926T3 (es)
PT (1) PT1622926E (es)
SI (1) SI1622926T1 (es)
TW (1) TW200510448A (es)
WO (1) WO2004096829A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2854402B1 (fr) * 2003-04-29 2008-07-04 Aventis Pharma Sa Nouveau procede et intermediaires de preparation de composes 19-nor-steroides
HU227112B1 (hu) * 2006-06-14 2010-07-28 Richter Gedeon Nyrt Ipari eljárás 17-alfa-acetoxi-11-béta-[4-(N,N-dimetil-amino)-fenil]-19-norpregna-4,9-dién-3,20-dion elõállítására és új intermedierek az eljáráshoz
CN105979780A (zh) 2013-12-11 2016-09-28 斯隆-凯特林癌症研究院 治疗前列腺癌的糖皮质激素抑制剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3264327A (en) * 1962-07-27 1966-08-02 Syntex Corp 17alpha-fluoro-, 17beta-chlorofluoroacetoxy- and 17beta-methyl-delta4-and delta5-androstene derivatives
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
FR2640977A2 (en) * 1982-06-11 1990-06-29 Roussel Uclaf New position-11 substituted 19-norsteroids and their application as medicinal products.
FR2771096B1 (fr) * 1997-11-17 2000-08-11 Hoechst Marion Roussel Inc Nouveaux 19-nor steroides, substitues en position 11beta, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant
FR2780060B1 (fr) * 1998-06-23 2000-08-04 Hoechst Marion Roussel Inc Nouveaux 19-nor steroides 17-halogenes, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant
FR2854402B1 (fr) * 2003-04-29 2008-07-04 Aventis Pharma Sa Nouveau procede et intermediaires de preparation de composes 19-nor-steroides

Also Published As

Publication number Publication date
US7449572B2 (en) 2008-11-11
TW200510448A (en) 2005-03-16
EP1622926B1 (fr) 2009-07-08
ATE435869T1 (de) 2009-07-15
FR2854403B1 (fr) 2008-07-11
EP1622926A2 (fr) 2006-02-08
JP4629030B2 (ja) 2011-02-09
SI1622926T1 (sl) 2009-12-31
PL1622926T3 (pl) 2009-12-31
JP2006525290A (ja) 2006-11-09
PT1622926E (pt) 2009-09-07
DE602004021918D1 (de) 2009-08-20
US20040224933A1 (en) 2004-11-11
CY1109434T1 (el) 2014-08-13
WO2004096829A2 (fr) 2004-11-11
FR2854403A1 (fr) 2004-11-05
ES2328927T3 (es) 2009-11-19
WO2004096829A3 (fr) 2005-02-03
AR044103A1 (es) 2005-08-24

Similar Documents

Publication Publication Date Title
DK1667986T3 (da) Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf
DK2508521T4 (da) Dimaleat af en aminocrotonylforbindelse og fremgangsmåde til fremstilling deraf
DK1608634T3 (da) Fremgangsmåder til isolering af krystallinsk form af 5-azacytidin
DK1716115T3 (da) Syntese af acyloxyalkylcarbamat-prodrug og mellemprodukter deraf
DK1824475T3 (da) Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol
DK1644384T3 (da) Fremgangsmåde og mellemprodukter til syntese af entecavir
DK1752443T3 (da) Ny krystallinsk form V af agomelatin, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dette
DK1831154T3 (da) Fremstilling af pregabalin og relaterede forbindelser
DK3385267T3 (da) Syntese af boronestere og syreforbindelser
DK1644021T3 (da) Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DK1656370T3 (da) Heterocykliske biarylforbindelser og fremgangsmåder til fremstilling og anvendelse af samme
DK1628530T3 (da) Fremgangsmåder og sammensætninger til forebyggelse og behandling af sepsis
DK1679058T3 (da) Farmaceutisk sammensætning til behandling af kardiovaskulære og cerebrovaskulære sygdomme
DK1840125T3 (da) Mellemprodukter til fremstilling af dioxan-2-alkylcarbamater
DK1606261T3 (da) Hidtil ukendt fremgangsmåde til fremstilling af roflumilast
DK2402005T3 (da) Formuleringer med langvarig frigivelse af nalbuphin
DK1512324T3 (da) Fremgangsmåde til dearomatisering af materialer stammende fra soja
DK1350765T3 (da) Fremgangsmåde til fremstilling af jernoxider
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
DK1353923T3 (da) Forbedret fremgangsmåde til syntese af carbapenem
DK1678297T3 (da) Fremgangsmåde til fremstilling af Gamma-carboxylerede proteiner
DK1578731T3 (da) Fremgangsmåde til fremstilling af pyrimidinforbindelser
DK1474689T3 (da) Fremgangsmåde til diagnosticering af inflammatoriske sygdomme ved anvendelse af calgranulin c